Myelodysplastic/Myeloproliferative Neoplasms Clinical Trials
3 recruiting trials for Myelodysplastic/Myeloproliferative Neoplasms. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Myelodysplastic/Myeloproliferative Neoplasms clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by UNC Lineberger Comprehensive Cancer Center (2), Barbara Ann Karmanos Cancer Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is biologic sample preservation procedure (other, 1 trial), followed by cytology specimen collection procedure, 3'-deoxy-3'-[18F]fluorothymidine.
Track Myelodysplastic/Myeloproliferative Neoplasms trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Registry of Older Patients With Cancer
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older...
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future....
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Myelodysplastic/Myeloproliferative Neoplasms, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Myelodysplastic/Myeloproliferative Neoplasms, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Myelodysplastic/Myeloproliferative Neoplasms, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.